Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications

Fibrosing interstitial lung disease (ILD) is one of the most important causes of morbidity and mortality in patients with connective tissue diseases (CTDs), which include systemic sclerosis, rheumatoid arthritis, Sjögren’s syndrome, idiopathic inflammatory myositis and systemic lupus erythematosus....

Descripción completa

Detalles Bibliográficos
Autores principales: Erre, Gian Luca, Sebastiani, Marco, Manfredi, Andreina, Gerratana, Elisabetta, Atzeni, Fabiola, Passiu, Giuseppe, Mangoni, Arduino A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813437/
https://www.ncbi.nlm.nih.gov/pubmed/33505482
http://dx.doi.org/10.7573/dic.2020-8-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813437/
https://www.ncbi.nlm.nih.gov/pubmed/33505482
http://dx.doi.org/10.7573/dic.2020-8-6

Ejemplares similares